Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon to Provide siRNAs to Odyssey Thera in Cell Signaling Studies

NEW YORK, Sept. 15 (GenomeWeb News) - Dharmacon and Odyssey Thera have signed a collaboration to study gene silencing in cell signaling pathways, the companies said today.

 

Under the agreement, Dharmacon, of Lafayette, Colo., will synthesize its siRNA reagents for targets that Odyssey Thera, of San Ramon, Calif., provides. These targets are associated with angiogenesis, apoptosis, inflammation, and other disease-related events, the companies said.  

 

Odyssey researchers will combine these siRNA reagents with the company's protein-fragment complementation assay, which is used to quantify and analyze signaling events in living human cells. Together, these technologies are expected to enable the researchers to analyze the way that gene silencing affects downstream events in cell signaling pathways, as well as measuring off-pathway effects.

 

Odyssey said it is planning to use the information gleaned through this collaboration in identification of novel targets, as well as potential nucleic acid and small molecule therapeutics, and high-throughput screening assays. Dharmacon said the collaboration will help it broaden its understanding of "the specificity and potency of siRNA's in the context of a cellular readout," according to a company statement.

 

The companies did not disclose the financial terms of the agreement.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.